LncRNA PTPRG-AS1 Promotes Breast Cancer Progression by Modulating the miR-4659a-3p/QPCT Axis
Collectively, the study demonstrates that lncRNA PTPRG-AS1 may act as a competing endogenous RNA by regulating the miR-4659a-3p/QPCT axis in BRCA progression. This lncRNA could potentially be a biomarker and therapeutic target for BRCA.
Authors
- Liu Yang (ORCID: https://orcid.org/0000-0001-8174-1633)
- Quanle Wang
- Bin Xu (ORCID: https://orcid.org/0000-0002-3389-3242)
- Zhenchuan Song (ORCID: https://orcid.org/0000-0003-3674-1946)
- Haijun Zhao (ORCID: https://orcid.org/0000-0003-3956-3372)
- Lixian Yang (ORCID: https://orcid.org/0000-0002-2396-6030)
- Xiaolong Li (ORCID: https://orcid.org/0000-0001-7493-2650)
- Shuo Liu (ORCID: https://orcid.org/0000-0002-2969-5876)
- Yanting Li (ORCID: https://orcid.org/0000-0003-2973-3016)
- Mengsi Zhou
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Xingtai People's Hospital (CN)
- First Hospital of Shijiazhuang (CN)
Publication Details
- Journal
- OncoTargets and Therapy
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/ott.s474898
- Citations
- 2
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.57